Home › NDC Lookup › Ingredients › Benzocaine › 55636-0384-04
endurance wipe Benzocaine 7 mg/100mg Cloth, 21 packets — NDC 55636-0384-04 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

endurance wipe Benzocaine 7 mg/100mg Cloth, 21 packets — NDC 55636-384-04 (Billing 55636-0384-04)

by Absorption Pharmaceuticals, LLC · 21 PACKET in 1 BOX / 1 mg in 1 PACKET

This is a package of 21 packets of endurance wipe Benzocaine 7 mg/100mg Cloth from Absorption Pharmaceuticals, LLC, marketed since Jun 2024 and currently FDA-listed.

NDC 55636-0384-04
🏷️ FDA NDC (as labeled) 55636-384-04 billing pads the product segment with a zero
This package
Contains21 packets Pack sizes2 compare ↓
Product page 55636-0384-03 Also comes in: 7 packets 55636-384-03
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 55636-384-04 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
55636 labeler · 384 product · 04 package
Package marketed since
Jun 1, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 5563638404 9
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Benzocaine (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0602-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0605-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0601-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0603-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0604-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0606-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 55636-384-04
Product NDC 55636-384
11-digit billing NDC 55636038404
UNII U3RSY48JW5
Application # M017
SPL Set ID 303db1de-94fc-4543-e063-6294a90a01b9
Established class (EPC) Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity
Chemical class Allergens
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-06-01
Route TOPICAL
Dosage form CLOTH
Substance BENZOCAINE
Why two NDCs? The FDA registers this code as 55636-384-04 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 55636-0384-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Endurance Wipe is an over-the-counter topical cloth product containing benzocaine. Benzocaine is a local anesthetic that is typically used to numb small areas of skin or mucous membranes on contact. This product is marketed as a monograph drug, meaning it follows FDA's established rules for its drug category rather than undergoing individual application review.

Supplement & herbal interactions

Some supplements/herbs that may interact with Benzocaine — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Benzocaine (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 7 packets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
55636-0384-03 55636-384-03 Main listing 7 PACKET in 1 BOX / 1 mg in 1 PACKET 2024-06-01 — Active
55636-0384-04 You're viewing this 21 PACKET in 1 BOX / 1 mg in 1 PACKET 2024-06-01 — Active

Pack size FAQ

What quantity is in this package?
This package contains 21 packets — 21 packet in 1 box / 1 mg in 1 packet.
How does this package differ from NDC 55636-0384-03?
Both are endurance wipe Benzocaine 7 mg/100mg Cloth — the drug itself is identical. This page's package is the 21 packets one, while NDC 55636-0384-03 is the 7 packets package.
What NDC number is used to bill for this package of endurance wipe Benzocaine 7 mg/100mg Cloth?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
endurance wipe 7 mg/100mgthis 55636-0384-04 Absorption 21 packets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Jun 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesPropylene Glycol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAbsorption Pharmaceuticals, LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code55636
First marketedJun 2024
Product typeHuman Otc Drug

More NDCs from Absorption Pharmaceuticals, LLC labeler code 55636

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 11 words ▾

Use For reducing oversensitivity in the male in advance of intercourse.

⏱️ Dosage and Administration 24 words ▾

Directions Apply a small amount to head shaft of penis before intercourse, or use as directed by a doctor. Wash product off after intercourse.

⚠️ Warnings 117 words ▾

Warnings For external use only. When using this product When using this product avoid contact with the eyes Stop use and seek a doctor if This product, used as directed, does not provide relief. Premature ejaculation may be due to a condition requiring medical supervision. You or your partner develop a rash or irritation, such as burning or itching. Symptoms persist.

When using this product When using this product avoid contact with the eyes

Stop use and seek a doctor if This product, used as directed, does not provide relief. Premature ejaculation may be due to a condition requiring medical supervision. You or your partner develop a rash or irritation, such as burning or itching. Symptoms persist.

🧪 Active Ingredient 4 words ▾

Active Ingredient Benzocaine 7%

🧪 Inactive Ingredients 4 words ▾

Inactive Ingredients Propylene Glycol

🎯 Purpose 4 words ▾

Purpose Male genital desensitizer

📄 Keep Out of Reach of Children 24 words ▾

Keep out of reach of children. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

📄 Package Label / Principal Display Panel ~1 min read ▾

Principal Display Panel PROMESCENT ® Last Longer endurance wipes delays your pleasure bit not your lover's 1 Wipe | Male Genital Desensitizer Do Not Flush SAVE OUTER CARTON FOR COMPLETE DRUG FACTS INDICATON: FOR REDUCING OVERSENSITIVITY IN IN THE MALE IN ADVANCE OF INTERCOURSE. Distributed by: Absorption Pharmaceuticals LLC. Questions?

Visit PROMESCENT.com Retain original packaging for complete product information. MADE IN USA WITH DOMESTIC &IMPORTED MATERIALS PROMESCENT ® BETTER IN BED ® Last Longer endurance wipes POCKET WIPES FOR WHEN YOU'RE ON THE GO more pleasure for you and your lover loved by lovers™ 7 Wipes Male Genital Desensitizer DO NOT FLUSH delays your pleasure bit not your lover's Incredible sex brings you closer Our endurance Wipes are designed to use anytime, anywhere and help you go the distance by reducing oversensitivity, creating more time for intimacy between you and your partner. v Extra strength formula v Gives you more control v Safe, easy to use, pocket-sized wipes DISTRIBUTED BY: Absorption Pharmaceuticals LLC.

4690 W. Post Rd #135 Las Vegas, NV 89118, USA Questions? Visit promescent.com Customer Service: 1-855-426-9500 To report serious adverse effects associated with this product, call 1-877-852-0106 MADE IN USA WITH DOMESTIC &IMPORTED MATERIALS ADJUSTABLE DOSING CONTAINS 7 WIPES INSTRUCCIONESY ADVERTENCIAS EN ESPAÑOL DISPONIBLES DENTRO DE LA CAJA.

7 Wipes SDW NDC:55636-384-03 Rev:04242025 21 Wipes BDW NDC:55636-384-04 Rev:04242025 LABEL LABEL LABEL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for endurance wipe (this brand).

Top reported reactions

Methaemoglobinaemia124
Drug Hypersensitivity61
Asthenia48
Nausea46
Dyspnoea38
Arthralgia36
Anxiety35

Age at onset

Neonate7
Infant3
Child2
Adolescent3
Adult79
Elderly34

Reporter sex

756 reports
Male · 35%
Female · 65%
Unknown · 1%

Serious outcomes

Hospitalization309
Life-threatening112
Death68
Disabling50
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 66 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Absorption Pharmaceuticals, LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 7 packets (55636-0384-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Absorption Pharmaceuticals, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 55636-0000-01 · Absorption 55636-0590-13 · Absorption →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.